[go: up one dir, main page]

AU1699397A - Methods of using integrin modulators - Google Patents

Methods of using integrin modulators

Info

Publication number
AU1699397A
AU1699397A AU16993/97A AU1699397A AU1699397A AU 1699397 A AU1699397 A AU 1699397A AU 16993/97 A AU16993/97 A AU 16993/97A AU 1699397 A AU1699397 A AU 1699397A AU 1699397 A AU1699397 A AU 1699397A
Authority
AU
Australia
Prior art keywords
methods
integrin modulators
integrin
modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16993/97A
Inventor
John B Davidson
Alexander V. Tatarintsev
Ali S. Turgiev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/585,190 external-priority patent/US5948821A/en
Priority claimed from US08/585,187 external-priority patent/US5863954A/en
Priority claimed from US08/584,038 external-priority patent/US5981602A/en
Priority claimed from US08/584,052 external-priority patent/US5856363A/en
Priority claimed from US08/585,188 external-priority patent/US5863955A/en
Application filed by Individual filed Critical Individual
Publication of AU1699397A publication Critical patent/AU1699397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU16993/97A 1996-01-11 1997-01-13 Methods of using integrin modulators Abandoned AU1699397A (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US08/585,190 US5948821A (en) 1992-06-30 1996-01-11 Methods of using ajoene
US08/585,187 US5863954A (en) 1992-06-30 1996-01-11 Contraceptive method using ajoene
US584052 1996-01-11
US584038 1996-01-11
US08/584,038 US5981602A (en) 1992-06-30 1996-01-11 Methods of using Ajoene for inhibiting integrin-mediated cell-cell fusion
US585187 1996-01-11
US08/584,052 US5856363A (en) 1992-06-30 1996-01-11 Methods of using ajoene
US585188 1996-01-11
US08/585,188 US5863955A (en) 1992-06-30 1996-01-11 Methods of using ajoene to inhibit an immune response
US585190 1996-01-11
US69889396A 1996-08-16 1996-08-16
US698893 1996-08-16
PCT/US1997/000583 WO1997025031A1 (en) 1996-01-11 1997-01-13 Methods of using integrin modulators

Publications (1)

Publication Number Publication Date
AU1699397A true AU1699397A (en) 1997-08-01

Family

ID=27560153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16993/97A Abandoned AU1699397A (en) 1996-01-11 1997-01-13 Methods of using integrin modulators

Country Status (3)

Country Link
EP (1) EP1014956A4 (en)
AU (1) AU1699397A (en)
WO (1) WO1997025031A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037914A1 (en) * 1997-02-26 1998-09-03 Toray Industries, Inc. Remedies for hepatitis
JP5037134B2 (en) 2003-10-17 2012-09-26 レハブ アル−ジャマル Tissue repair
GB0703652D0 (en) * 2007-02-26 2007-04-04 Univ Bradford Method for the allosteric modulation of beta1 integrin
KR101176618B1 (en) 2010-04-01 2012-08-23 서울대학교산학협력단 Composition comprising ajoene for preventing or treating a disease caused by overexpression of LXR-alpha

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9023337D0 (en) * 1990-10-26 1990-12-05 Interprise Ltd Antimicrobial composition

Also Published As

Publication number Publication date
WO1997025031A1 (en) 1997-07-17
EP1014956A4 (en) 2001-11-07
EP1014956A1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
AU9790198A (en) Compounds and methods
AU4261697A (en) Compounds and methods
AU8366498A (en) Optical transmitter system and method
AU5881998A (en) Modulator and modulation method
AU7592998A (en) Modulators of tissue regeneration
AU3761297A (en) Synchronous modulator and methods for synchronous modulation
AU5270598A (en) Single sideband modulators
AU4531197A (en) An optical modulator
AU6928098A (en) Optical modulator
AU7317896A (en) Solubilisation methods
AU5055996A (en) Switched-inverter modulator
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU3118297A (en) Sok-1 and methods of use
AU7020896A (en) Balanced modulator
AU1887297A (en) Optical modulator
AU1691297A (en) Cytoplasmic modulators of integrin binding
AU1570199A (en) Methods of lyophilizing solutions
AU2624797A (en) Balanced modulator
AU1699397A (en) Methods of using integrin modulators
AU2650797A (en) Cosmetic
AU2500797A (en) Methods of modulating t-cell activation
AU4931697A (en) Operation of optical modulators
AU7568396A (en) Method of preparing 2-trifluoromethoxybenzene sulphonamide
AU2002300151A1 (en) Optical devices and method